{"title":"沙特阿拉伯人自述抗精神病药物副作用与抑郁症的关系","authors":"Y. Al Ruthia","doi":"10.1016/j.etdah.2023.100068","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The relationship between antipsychotics’ side effects and depression/anxiety among Arabic-speaking patients with different psychiatric conditions has not been examined before. Therefore, the aim of this study was to examine the association between antipsychotics’ side effects and depression and anxiety.</div></div><div><h3>Methods</h3><div>This was a single-centre prospective cross-sectional study in which Arabic-speaking adult (≥18 yrs.) patients, treated with antipsychotics in Riyadh, Saudi Arabia, were recruited. The Arabic versions of the Glasgow antipsychotic side effect scale (GASS), Patient Health Questionnaire 9-item (PHQ-9), and Generalized Anxiety Scale 7-item (GAD-7) were used to measure antipsychotics’ side effects, depression, and anxiety, respectively. Multiple linear regressions were conducted.</div></div><div><h3>Results</h3><div>One-hundred patients consented to participate and were included in the analysis. The mean age of the patients was 38 years, 72% were females, 40% had a college degree or higher, and 73% had no comorbidities. Patients with higher PHQ-9 scores (β=0.883, 95% CI [0.642–1.126], p<0.0001), and GAD-7 scores (β=0.797, 95% CI [0.412–1.182], p<0.0001) were more likely to have higher GASS scores controlling for age, gender, and education.</div></div><div><h3>Conclusions</h3><div>Patients with more severe forms of depression and anxiety are more likely to report higher rates of antipsychotics’ adverse events.</div></div>","PeriodicalId":72899,"journal":{"name":"Emerging trends in drugs, addictions, and health","volume":"4 ","pages":"Article 100068"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Relationship between Self-Report Antipsychotics Side Effects and Depression in Saudi Arabia\",\"authors\":\"Y. Al Ruthia\",\"doi\":\"10.1016/j.etdah.2023.100068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>The relationship between antipsychotics’ side effects and depression/anxiety among Arabic-speaking patients with different psychiatric conditions has not been examined before. Therefore, the aim of this study was to examine the association between antipsychotics’ side effects and depression and anxiety.</div></div><div><h3>Methods</h3><div>This was a single-centre prospective cross-sectional study in which Arabic-speaking adult (≥18 yrs.) patients, treated with antipsychotics in Riyadh, Saudi Arabia, were recruited. The Arabic versions of the Glasgow antipsychotic side effect scale (GASS), Patient Health Questionnaire 9-item (PHQ-9), and Generalized Anxiety Scale 7-item (GAD-7) were used to measure antipsychotics’ side effects, depression, and anxiety, respectively. Multiple linear regressions were conducted.</div></div><div><h3>Results</h3><div>One-hundred patients consented to participate and were included in the analysis. The mean age of the patients was 38 years, 72% were females, 40% had a college degree or higher, and 73% had no comorbidities. Patients with higher PHQ-9 scores (β=0.883, 95% CI [0.642–1.126], p<0.0001), and GAD-7 scores (β=0.797, 95% CI [0.412–1.182], p<0.0001) were more likely to have higher GASS scores controlling for age, gender, and education.</div></div><div><h3>Conclusions</h3><div>Patients with more severe forms of depression and anxiety are more likely to report higher rates of antipsychotics’ adverse events.</div></div>\",\"PeriodicalId\":72899,\"journal\":{\"name\":\"Emerging trends in drugs, addictions, and health\",\"volume\":\"4 \",\"pages\":\"Article 100068\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging trends in drugs, addictions, and health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667118223000193\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging trends in drugs, addictions, and health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667118223000193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
前言:在患有不同精神疾病的阿拉伯语患者中,抗精神病药物的副作用与抑郁/焦虑之间的关系尚未被研究过。因此,本研究的目的是研究抗精神病药物的副作用与抑郁和焦虑之间的关系。方法:这是一项单中心前瞻性横断面研究,招募了在沙特阿拉伯利雅得接受抗精神病药物治疗的阿拉伯语成人(≥18岁)患者。采用阿拉伯语版格拉斯哥抗精神病药物副作用量表(GASS)、患者健康问卷9项(PHQ-9)和广泛性焦虑量表7项(GAD-7)分别测量抗精神病药物的副作用、抑郁和焦虑。进行了多元线性回归。结果100例患者同意参与并纳入分析。患者平均年龄38岁,72%为女性,40%为大学及以上学历,73%无合并症。PHQ-9评分较高的患者(β=0.883, 95% CI [0.642-1.126], p<0.0001)和GAD-7评分较高的患者(β=0.797, 95% CI [0.412-1.182], p<0.0001)在控制年龄、性别和教育程度的情况下,GASS评分较高的可能性更大。结论抑郁和焦虑形式越严重的患者报告抗精神病药物不良事件的发生率越高。
The Relationship between Self-Report Antipsychotics Side Effects and Depression in Saudi Arabia
Introduction
The relationship between antipsychotics’ side effects and depression/anxiety among Arabic-speaking patients with different psychiatric conditions has not been examined before. Therefore, the aim of this study was to examine the association between antipsychotics’ side effects and depression and anxiety.
Methods
This was a single-centre prospective cross-sectional study in which Arabic-speaking adult (≥18 yrs.) patients, treated with antipsychotics in Riyadh, Saudi Arabia, were recruited. The Arabic versions of the Glasgow antipsychotic side effect scale (GASS), Patient Health Questionnaire 9-item (PHQ-9), and Generalized Anxiety Scale 7-item (GAD-7) were used to measure antipsychotics’ side effects, depression, and anxiety, respectively. Multiple linear regressions were conducted.
Results
One-hundred patients consented to participate and were included in the analysis. The mean age of the patients was 38 years, 72% were females, 40% had a college degree or higher, and 73% had no comorbidities. Patients with higher PHQ-9 scores (β=0.883, 95% CI [0.642–1.126], p<0.0001), and GAD-7 scores (β=0.797, 95% CI [0.412–1.182], p<0.0001) were more likely to have higher GASS scores controlling for age, gender, and education.
Conclusions
Patients with more severe forms of depression and anxiety are more likely to report higher rates of antipsychotics’ adverse events.